Vascular endothelial growth factor

Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study

B. - L. Shen, Qu, Q. - S., Miao, S. - Z., and Zhang, Y. - X., Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study, vol. 14, pp. 11119-11125, 2015.

We conducted this case-control study to assess the role of the VEGF -2578C/A, +1612G/A, +936C/T and -634G/C gene polymorphisms in the development of renal cell carcinoma (RCC). A hospital-based case-control study was conducted in a 360 consecutive primary RCC patients and 360 age and gender-matched controls during January 2010 and January 2014. The polymerase chain reaction-restriction fragment length polymorphism was used for VEGF -2578C/A, +1612G/A, +936C/T and -634G/C genotyping.

Effects of icariin on the expression of ER, VEGF, and KDR in the endometrial cells of thin endometrium

A. W. Le, Shan, L., Wang, Z. H., Dai, X. Y., Xiao, T. H., and Zuo, R., Effects of icariin on the expression of ER, VEGF, and KDR in the endometrial cells of thin endometrium, vol. 14, pp. 11250-11258, 2015.

We explored the effects of icariin on the expression of estrogen receptor (ER), vascular endothelial growth factor (VEGF), and kinase insert domain receptor (KDR) in the endometrial cells of the thin endometrium. Primary endometrial cells were obtained and divided into a blank control group, a high-, a middle-, and a low-dose icariin groups, as well as an estrogen treatment group to undergo cellular identification by immunocytochemistry. The expression levels of ER, VEGF, and its receptor were estimated by western blotting.

Pages

Subscribe to Vascular endothelial growth factor